Basic and Core Value Dossiers for Medical Technologies

Choose Your Perfect Dossier

Three evidence packs: Start-Up, Basic, and Comprehensive, so you always have the right ammunition for every stage of your MedTech journey.

Feature	Start-up	Basic	Comprehensive
Size, pages	15	25	40-60
Appendixes	No	No	Yes
PRISMA-compliant reporting	Selective reporting of key publications	Selective reporting of key publications	Yes
Timelines, weeks	4	4 - 6	12-16
Number of revisions from client	0	1	2
Use case	Marketing, sales, procurement, clinical stakeholder engagement	Marketing, sales, procurement, clinical stakeholder engagement	Marketing, sales, procurement, clinical stakeholder engagement, reimbursement, HTA
Risk of bias assessment	No	No	Yes, for product studies
Communication	No (client fills in request form with detailed PICO)	Kick-off, delivery meeting	Kick-off, delivery meeting, bi-weekly updates by email or TC

Technological Coverage of Our Services

We provide services for major types of medical technologies:

Implantable devices

Interventional procedures

Non-interventional procedures

In-Vitro diagnostics (IVD) tests

Medical aids

Our team has worked on hundreds of reimbursement/HEOR projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy, in-vitro diagnostic tests, companion diagnostic tests (CDx), medical aids, health apps, remote monitoring technologies, decision support systems, artificial intelligence (AI) technologies, amongst others.

Why Partner with MTRC?

Be Confident in the Results

We are accredited by the United Kingdom Accreditation Service (UKAS) as an ISO 9001:2015 certified vendor, specialised in medical technologies market access. Unlike many of our competitors, we dedicate 100% of our time and focus to the area of medical technologies, so that our clients enjoy higher quality services at a lower cost. We are also probably the largest Med Tech market access consultancy in Europe, which helps us accumulate unique knowledge and insights. MTRC is a proud member of ABHI, the UK’s leading industry association for health technology (HealthTech)

Avoid the Hassle of Working with Multiple Vendors

We specialize in Pan-European projects and have worked in 15 countries in Europe. You can save time, effort, and money by working with a single experienced vendor vs contracting several consultants individually.

We provide support in Austria, Belgium, Denmark, England, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Spain, Sweden, and Switzerland

Spend Less on Consulting

We understand the budgetary challenges of the med tech industry and can therefore offer a cost-effective approach to our specialised services. Twenty-three percent (23%) of our current business comes from small to medium-sized enterprises (SMEs) – a testament to our unique and personal approach to solve your budgetary challenges

Direct Access to Senior Leadership

Small enough to ensure significant personal attention, and large enough to address your needs, our boutique consultancy guarantees that each project enjoys the attention it deserves with direct access to our senior leaders

Make Decisions and Advance your Business Quickly

We appreciate the time-sensitive nature of market access. Being a flexible team, we are not afraid to go beyond regular working hours to meet the high expectations of our clients. For every type of project, we offer the shortest possible turnaround times

Global, European

or Country-Specific Dossiers

Usually, dossiers are developed from a global or European perspective, which means that the selection of epidemiological data, treatment patterns, patient pathways and other data is based primarily on either global or European sources.

Clinical effectiveness data are always based on global evidence.

The scope of the dossier is discussed with the client to adjust the methodological approach. In some cases, MTRC will limit the data to key European markets (e.g., EU5 – France, Germany, Italy, Spain, and the UK).

Our team can apply our deep knowledge of the requirements of different reimbursement and Health Technology Assessment stakeholders in Europe to ensure that our clients receive a truly useful value dossier. MTRC has worked on reimbursement/HTA submission projects in Belgium, France, Germany, Italy, Norway, the Netherlands, Poland, Sweden, and the UK.

Get Insights from MTRC Free Analytical Reports

Explore free MTRC analytical reports and white papers for in-depth insights into value dossier development and value communication for medical technologies in Europe

Explore MTRC research papers:

Explore more white papers

MTRC in Numbers

An extremely specialised boutique consultancy with a global impact

Full-time employees

1,012

Projects

233

Clients

Regular clients from the top 30 med tech companies

23%

Of business comes from Small to Medium-sized Enterprises (SMEs)

Featured Publications

MTRC members and associated researchers have a proven track record with the publication of results of systematic literature reviews and health economic analyses. Some of the examples of our publications are presented below.

Borisenko O, Maslov A, Baka A, Anelli MC, Das L, Roscigno M, Conti A.

Utility of MpMRI and phi in detection of prostate cancer in Italy: a decision analytic modeling

Anticancer Research Abstracts of the 34th Annual Meeting of the Italian Society of Uro-Oncology (SIUrO), 2024(44): 4617-4661

Borisenko O, Maslov A, Baka A, Anelli MC, Das L, Terracciano D.

EE777 Diagnostic Pathways for Prostate Cancer in Italy: A Cost-Consequences Analysis

Value in Health 2024 Dec, Volume 27, Issue 12, S208

Moola S, Tyagi J, Miller M, Gudi N, Pettigrew S, Bhaumik S.

Interventions addressing maternal and child health among the urban poor and homeless: an overview of systematic reviews

J Med Econ. 2018 Jan 10:1-9.

Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed R Ahmed.

Clinical Indications, Utilization and Funding of Bariatric Surgery in Europe

Obes Surg. 2015 Aug;25(8):1408-16.

All publications